Lupin protein hydrolysates effectively inhibited the two enzymes involved in the management of diabetes (α-glucosidase and α-amylase) through disruption of enzyme-substrate interactions at the active site of the enzyme and delayed postprandial hyperglycaemia. Here, NT5C3A is linked to diabetes mellitus.